LUMO | Lumos Pharma, Inc. | [NASD]
Index- P/E- EPS (ttm)-3.68 Insider Own9.70% Shs Outstand8.24M Perf Week8.20%
Market Cap30.09M Forward P/E- EPS next Y-3.26 Insider Trans-0.34% Shs Float5.57M Perf Month23.46%
Income-30.70M PEG- EPS next Q-1.09 Inst Own30.80% Short Float / Ratio3.03% / 13.08 Perf Quarter14.80%
Sales2.10M P/S14.33 EPS this Y-1.60% Inst Trans7.89% Short Interest0.17M Perf Half Y-25.73%
Book/sh6.37 P/B0.59 EPS next Y18.10% ROA-40.80% Target Price18.33 Perf Year-50.84%
Cash/sh7.25 P/C0.52 EPS next 5Y15.20% ROE-48.30% 52W Range2.95 - 9.56 Perf YTD4.31%
Dividend- P/FCF- EPS past 5Y29.10% ROI-53.70% 52W High-60.61% Beta0.93
Dividend %- Quick Ratio12.60 Sales past 5Y-44.40% Gross Margin- 52W Low27.64% ATR0.27
Employees33 Current Ratio12.60 Sales Q/Q600.00% Oper. Margin- RSI (14)61.32 Volatility8.37% 7.97%
OptionableNo Debt/Eq0.00 EPS Q/Q3.50% Profit Margin- Rel Volume1.58 Prev Close3.68
ShortableYes LT Debt/Eq0.00 EarningsMay 03 AMC Payout- Avg Volume12.88K Price3.77
Recom2.00 SMA2010.19% SMA5012.68% SMA200-30.31% Volume20,388 Change2.18%
Date Action Analyst Rating Change Price Target Change
Mar-11-21Upgrade Stifel Hold → Buy $4 → $24
Dec-03-20Initiated Cantor Fitzgerald Buy $32
Aug-26-20Initiated Piper Sandler Overweight $26
Aug-17-20Resumed ROTH Capital Buy $51
Aug-04-20Initiated H.C. Wainwright Buy $33
May-25-23 08:00AM
May-22-23 09:00AM
May-08-23 08:00AM
May-03-23 04:05PM
Apr-27-23 09:00AM
09:00AM Loading…
Apr-19-23 09:00AM
Mar-09-23 04:05PM
Mar-05-23 02:00PM
Mar-01-23 04:05PM
Feb-28-23 04:05PM
Feb-15-23 04:05PM
Jan-03-23 09:00AM
Dec-12-22 07:30AM
Nov-29-22 04:05PM
Nov-22-22 04:05PM
06:10AM Loading…
Nov-14-22 06:10AM
Sep-26-22 04:05PM
Aug-31-22 09:00AM
Aug-16-22 07:30AM
Aug-09-22 04:01PM
Jul-27-22 04:05PM
Jul-24-22 08:27AM
Jul-20-22 08:32PM
May-16-22 04:05PM
May-10-22 04:01PM
May-06-22 10:25AM
May-05-22 09:00AM
Apr-26-22 09:00AM
Apr-11-22 08:30AM
04:05PM Loading…
Mar-23-22 04:05PM
Mar-10-22 04:01PM
Feb-23-22 09:00AM
Feb-14-22 12:05PM
Jan-05-22 09:00AM
Dec-28-21 09:38AM
Dec-21-21 09:38AM
Dec-16-21 09:38AM
Dec-08-21 09:38AM
Nov-24-21 10:00AM
Nov-15-21 11:14AM
Nov-10-21 05:06PM
Nov-08-21 10:42AM
Nov-03-21 04:01PM
Oct-21-21 04:05PM
Sep-02-21 08:00AM
Aug-16-21 09:58AM
Aug-05-21 08:00AM
Aug-03-21 08:00AM
Aug-02-21 08:00AM
Jul-26-21 04:18PM
Jul-22-21 08:00AM
Jul-20-21 04:01PM
Jun-28-21 08:00AM
May-19-21 09:00AM
May-13-21 09:00AM
May-05-21 04:01PM
Apr-28-21 09:00AM
Apr-27-21 08:00AM
Apr-20-21 04:05PM
Apr-14-21 04:05PM
Mar-20-21 11:00AM
Mar-11-21 04:05PM
Mar-09-21 04:05PM
Mar-04-21 09:00AM
Mar-02-21 04:05PM
Feb-22-21 04:15PM
Feb-16-21 04:01PM
Dec-18-20 09:00AM
Dec-16-20 02:19AM
Nov-30-20 05:35PM
Nov-23-20 07:43PM
Nov-10-20 04:01PM
Nov-03-20 12:30PM
Oct-29-20 09:00AM
Oct-27-20 04:01PM
Aug-27-20 09:00AM
Aug-13-20 04:01PM
Jul-28-20 04:01PM
Jul-27-20 04:05PM
Jun-19-20 08:21AM
Jun-10-20 03:41PM
May-28-20 04:01PM
May-27-20 04:27PM
May-26-20 10:36AM
Apr-24-20 08:00AM
Apr-02-20 04:05PM
Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its primary product candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 3 clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
McKew John C.Chief Scientific OfficerApr 04Sale3.272,2147,24023,207Apr 04 05:22 PM
McKew John C.Chief Scientific OfficerFeb 02Sale3.534391,55026,457Feb 03 05:03 PM
McCracken Joseph SDirectorNov 16Buy5.034,00020,12015,721Nov 18 04:31 PM
Hawkins Richard JChief Executive OfficerSep 23Buy8.802081,8304,469Sep 23 05:05 PM
Hawkins Richard JChief Executive OfficerSep 21Buy8.842,21419,5724,261Sep 23 05:05 PM
Hawkins Richard JChief Executive OfficerSep 20Buy8.751,50613,1782,047Sep 21 06:45 PM
Hawkins Richard JChief Executive OfficerSep 19Buy8.655414,680541Sep 21 06:45 PM
McCracken Joseph SDirectorAug 25Buy8.603,17027,26211,721Aug 26 04:59 PM
Raffin Thomas A.DirectorAug 25Buy8.461,1509,7299,406Aug 26 05:00 PM
McKew John C.Chief Scientific OfficerAug 02Sale8.113,40727,63124,602Aug 03 11:25 AM
McKew John C.Chief Scientific OfficerJun 06Sale7.621691,28829,102Jun 07 04:23 PM